OssDsign AB, an Uppsala, Sweden-based medtech company, raised SEK93m (€9.6m) in equity financing.
The round was led by new investors SEB Venture Capital and Fouriertransform with continued investment from Karolinska Development.
The company will use the funds for the market expansion of its product line of craniofacial implants.
Led by Anders Lundqvist, CEO, OssDsign is dedicated to creating regenerative implants for improved healing of bone defects and deficits in skull, facial and other types of surgery. It offers Craniomosaic for cranioplasty and Sculpter for facial reconstruction, which are currently available in Germany, the United Kingdom and the Nordic countries, with further expansion in Europe scheduled for 2016.
The company is working with regulatory authorities to expand access for its products in new key markets, with clearance expected in the US in 2016.
FinSMEs
04/11/2015